ArticleFrontiers in oncology2023

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer.

Jiale Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.